MARKET

SLP

SLP

Simulations Plus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

34.83
+0.23
+0.66%
After Hours: 34.83 0 0.00% 16:09 11/15 EST
OPEN
34.60
PREV CLOSE
34.60
HIGH
35.31
LOW
34.52
VOLUME
87.05K
TURNOVER
--
52 WEEK HIGH
41.95
52 WEEK LOW
17.18
MARKET CAP
612.72M
P/E (TTM)
79.81
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SLP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SLP News

  • Simulations Plus Partners with Large Pharmaceutical Company to Enhance the Mechanistic Oral Absorption (ACAT) Model in GastroPlus
  • Business Wire.2d ago
  • Simulations Plus EPS beats by $0.02, beats on revenue
  • seekingalpha.3d ago
  • Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.3d ago
  • Simulations Plus (SLP) Beats Q4 Earnings and Revenue Estimates
  • Zacks.3d ago

More

Industry

Advanced Medical Equipment & Technology
+2.55%
Healthcare Equipment & Supplies
+1.69%

Hot Stocks

Name
Price
%Change

About SLP

Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.
More

Webull offers Simulations Plus, Inc. (SLP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.